Tag: Targaxan

Approved by the FDA for certain conditions since 2004, Targaxan is a gut-specific antibiotic that acts locally rather than being absorbed into the bloodstream. This unique pharmacological property is central to understanding **how does Targaxan work** to address specific gastrointestinal disorders.

Targaxan, an antibiotic containing the active substance rifaximin, is prescribed for specific gastrointestinal conditions where its timing can significantly impact treatment efficacy. Knowing precisely when to take Targaxan is crucial for managing conditions like hepatic encephalopathy, irritable bowel syndrome with diarrhea (IBS-D), and traveler's diarrhea, as dosing schedules vary depending on the specific ailment.

Targaxan, containing the active ingredient rifaximin, is a specialized, non-systemic antibiotic that works primarily within the gut. Unlike systemic antibiotics that enter the bloodstream, Targaxan remains localized to target intestinal bacteria, making it effective for treating specific gastrointestinal and liver-related conditions.